A Probe for NLRP3 Inflammasome Inhibitor MCC950 Identifies Carbonic Anhydrase 2 as a Novel Target

[Image: see text] Inhibition of inflammasome and pyroptotic pathways are promising strategies for clinical treatment of autoimmune and inflammatory disorders. MCC950, a potent inhibitor of the NLR-family inflammasome pyrin domain-containing 3 (NLRP3) protein, has shown encouraging results in animal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennedy, Cassandra R., Goya Grocin, Andrea, Kovačič, Tristan, Singh, Ravi, Ward, Jennifer A., Shenoy, Avinash R., Tate, Edward W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218299/
https://www.ncbi.nlm.nih.gov/pubmed/34003636
http://dx.doi.org/10.1021/acschembio.1c00218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218299/
https://www.ncbi.nlm.nih.gov/pubmed/34003636
http://dx.doi.org/10.1021/acschembio.1c00218

Ejemplares similares